CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $729,889 | +41.2% | 48,953 | +3.7% | 0.01% | +66.7% |
Q2 2023 | $516,982 | +294.6% | 47,213 | +11.7% | 0.00% | +200.0% |
Q1 2022 | $131,000 | +5.6% | 42,257 | +14.7% | 0.00% | 0.0% |
Q4 2021 | $124,000 | -10.1% | 36,834 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $138,000 | -18.3% | 37,936 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $169,000 | -7.7% | 38,837 | -3.8% | 0.00% | 0.0% |
Q1 2021 | $183,000 | -20.8% | 40,372 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $231,000 | -23.0% | 40,265 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $300,000 | +102.7% | 41,420 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $148,000 | +146.7% | 42,362 | +3.9% | 0.00% | – |
Q1 2020 | $60,000 | -29.4% | 40,777 | -5.5% | 0.00% | – |
Q4 2019 | $85,000 | -61.9% | 43,133 | -0.8% | 0.00% | -100.0% |
Q3 2019 | $223,000 | -29.0% | 43,497 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $314,000 | -37.8% | 43,799 | +15.2% | 0.00% | -50.0% |
Q1 2019 | $505,000 | +65.6% | 38,005 | -2.0% | 0.00% | +100.0% |
Q4 2018 | $305,000 | -29.6% | 38,794 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $433,000 | -15.9% | 39,093 | +1.8% | 0.00% | -50.0% |
Q2 2018 | $515,000 | – | 38,389 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |